Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 251,510 | 278,839 | 264,493 | 274,019 | 540,856 |
| Marketable Securities | 494,450 | 494,871 | 358,560 | 468,141 | 392,888 |
| Receivables | 106,446 | 34,174 | 226,396 | 44,510 | 108,285 |
| Inventories | 11,545 | 13,511 | 10,240 | 10,263 | 8,749 |
| Other current assets | 87,510 | 107,663 | 0 | 0 | 0 |
| TOTAL | $978,276 | $974,590 | $919,512 | $868,028 | $1,128,942 |
| Non-Current Assets | |||||
| PPE Net | 44,800 | 49,120 | 129,643 | 133,538 | 138,413 |
| Intangibles | 113,462 | 113,080 | 112,958 | 112,027 | 107,478 |
| Other Non-Current Assets | 39,974 | 43,099 | 174,436 | 179,399 | 185,585 |
| TOTAL | $198,236 | $205,299 | $417,037 | $424,964 | $431,476 |
| Total Assets | $1,176,512 | $1,179,889 | $1,336,549 | $1,292,992 | $1,560,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,578 | 15,227 | 50,595 | 34,162 | 41,579 |
| Accrued Expenses | 107,165 | 115,586 | 86,697 | 132,165 | 211,165 |
| Other current liabilities | 185,647 | 189,769 | 132,531 | 142,031 | 219,596 |
| TOTAL | $459,950 | $429,869 | $389,138 | $422,170 | $1,154,416 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 140,053 | 104,251 | 113,763 | 108,334 | 675,067 |
| Other Non-Current Liabilities | 483,281 | 507,318 | 458,153 | 483,853 | 529,298 |
| TOTAL | $844,315 | $906,692 | $909,786 | $946,465 | $1,029,843 |
| Total Liabilities | $1,304,265 | $1,336,561 | $1,298,924 | $1,368,635 | $2,184,259 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 162,936 | 162,499 | 162,422 | 161,970 | 160,844 |
| Common Shares | 1,650 | 1,648 | 1,645 | 1,642 | 1,619 |
| Retained earnings | -4,568,148 | -4,585,675 | -4,383,296 | -4,489,804 | -5,008,450 |
| Other shareholders' equity | 1,989 | -1,408 | -917 | 1,670 | -22,413 |
| TOTAL | $-127,753 | $-156,672 | $37,625 | $-75,643 | $-623,841 |
| Total Liabilities And Equity | $1,176,512 | $1,179,889 | $1,336,549 | $1,292,992 | $1,560,418 |